WHO世界卫生组织：2024年增强淋病抗菌药物监测计划（EGASP）：淋病治疗优化报告（英文版）

The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) monitors Neisseria gonorrhoeae antimicrobial resistance to guide treatment optimization. It aligns with the WHO Global Action Plan on AMR and the Global Antimicrobial Resistance and Use Surveillance System (GLASS), providing quality-assured data to inform global and national guidelines.The first EGASP report (data from 2015–2022) covered 4 countries, while the 2024 report (data of 2023) expanded to 9, showing rising resi